We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6857:TSEAdvantest Corp. Analysis

Data as of 2026-08-29 - not real-time

¥35,270.00

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Advantest Corporation trades at ¥35,270.00, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has gained 11.9% over the past 30 days. Momentum indicators put RSI at 56.1 (neutral) with MACD reading bearish. The recent range runs from support at ¥30,080.00 up to resistance at ¥38,730.00.
Valuation screens as overvalued: a P/E of 68.5 sits above the sector average of 35.7. Analyst price targets sit 17.3% above the current price. Revenue is growing at 39.3% on a 37.3% profit margin. The 0.17% dividend yield looks covered by current payout levels.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 88.1%, a beta of 1.75 and a maximum drawdown of 29.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

Advantest Corporation recently presented at the OCP APAC Summit 2026 in Taipei, where Kotaro Hasegawa highlighted the...The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...Advantest Extends SiConic® Ecosystem to DFT Engineering, Accelerating Production-Ready Test Development

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 25952.30
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 68.5 versus sector average of 35.7
  • Trading above the 200-day average of 25952.30

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 68.5 versus sector average of 35.7
  • Analyst targets imply +17.3% versus the current price
  • Profit margin of 37.3% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth39.30%
Profit Margin37.33%
P/E Ratio68.5
ROE56.89%
ROA29.25%
Debt/Equity10.37
P/B Ratio24.5
Op. Cash Flow¥425.5B
Free Cash Flow¥349.9B
Industry P/E35.7

Technical Analysis

TrendBullish
RSI56.1
Support¥30,080.00
Resistance¥38,730.00
MA 20¥34,492.00
MA 50¥31,754.10
MA 200¥25,952.30
MACDBearish
VolumeDecreasing
Fear & Greed Index95.66

Valuation

Fair Value¥17,390.75
Target Price¥41,361.91
Upside/Downside17.27%
GradeOvervalued
TypeGrowth
Dividend Yield0.17%

Risk Assessment

Beta1.75
Volatility88.12%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.